Viewing StudyNCT00082095



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00082095
Status: TERMINATED
Last Update Posted: 2014-10-09
First Post: 2004-04-29

Brief Title: To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Keywords:
Name View
Xeloda View
Metastatic breast cancer View
Breast Cancer View
Pegylated Liposomal Doxorubicin View
Capecitabine View
DOXIL View